UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.
Dr. Hendrik Luesch and a team of researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.
Postdoctoral associate Laura E. Hanold, Ph.D., won a UF Health Cancer Center trainee award at the organization’s Virtual Research Symposium, Dec. 8-10. Hanold, whose faculty mentor is medicinal chemistry professor Jane Aldrich, Ph.D., was one of 14 trainee winners from the university’s health colleges. Laura Hanold, Ph.D. Hanold’s…
Dr. Chris McCurdy explains how science is attempting to answer safety questions around kratom in this Conversation story.
McCurdy began researching kratom in 2005 and the study represents the first time his team’s kratom research has appeared on a journal cover.
Kelton Schleyer, a medicinal chemistry graduate student in Dr. Lina Cui’s lab, is one of five health college students to receive a 2020 UF Health Cancer Center, or UFHCC, award. The $10,000 award recognizes and supports outstanding predoctoral candidates conducting innovative cancer research. Kelton Schleyer Schleyer’s research develops molecular probes…
Bodor has earned international recognition as a leader in drug discovery, design and delivery and serves as a graduate research professor emeritus in the UF College of Pharmacy.
UF researchers found kratom delivered significant pain-relieving benefits, reduced opioid withdrawal symptoms and caused minimal respiratory depression.
This paper was highlighted by Cancer Discovery, one of the top journals in cancer research.
The Chemistry-Biology Interface Training Program at the University of Florida was established in spring 2020.